Trial intelligence / Profile preview

AMDC in Female Patients with Stress Urinary Incontinence

2011-003599-35Phase 3Completed

Sponsor
Cook MyoSite
Start
Dec 2011
Modality
Cell Therapies
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in stress urinary incontinence (SUI) comparing AMDC with Placebo (2 arms). Primary endpoint: Number of stress incontinence episodes or pad weight. Started Dec 2011; status: completed.

02

Drugs

AMDC-USR
03

Conditions

stress urinary incontinence (SUI)

Beyond the preview

Go deeper on 2011-003599-35.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2011-003599-35.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call